In the [[United Kingdom|UK]] it is considered a possible carcinogen and so its licence is restricted to patients who already have a diagnosis of terminal cancer. It is mainly used in [[palliative care]] to counteract the constipating effects of [[opioids]]. Its  [[British Approved Name]] was '''danthron''', but it has now been changed to "dantron", the recommended International Nonproprietary Name.<ref name=BNF>[http://www.bnf.org/ British National Formulary website] (requires free registration)</ref>

 
== Side effects ==
